ArticleCancer chemotherapy and pharmacology2014

A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.

Carlos R Becerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.